Hypoparathyroidism treatment gets US boost

Israel’s Entera Bio has obtained orphan status from the US FDA for its oral treatment for hypoparathyroidism (decreased function of the parathyroid glands). The condition results in muscle cramping, twitching, or involuntary contraction, and several other symptoms.
http://www.globes.co.il/en/article-dna-biomedical-jumps-on-orphan-drug-status-1000933656

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.